[1]
Sara Zahra Omidi et al. 2026. TARGETING TYPE I INTERFERON SIGNALING IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL AND SAFETY PERSPECTIVES ON ANIFROLUMAB THERAPY. International Journal of Innovative Technologies in Social Science. 2, 2(50) (Jun. 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5467.